Viking Therapeutics
VKTX
#3883
Rank
A$5.00 B
Marketcap
A$39.23
Share price
-2.64%
Change (1 day)
-32.38%
Change (1 year)

Earnings for Viking Therapeutics (VKTX)

Earnings in 2026 (TTM): -A$0.92 Billion

According to Viking Therapeutics 's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -A$0.54 Billion a decrease over its 2024 earnings that were of -A$0.17 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Viking Therapeutics from 2014 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$0.92 Billion69.37%
2025 -A$0.54 Billion227.05%
2024 -A$0.17 Billion28.02%
2023 -A$0.13 Billion24.73%
2022 -A$0.11 Billion25.24%
2021 -A$82.44 Million39.23%
2020 -A$59.21 Million53.21%
2019 -A$38.65 Million16.84%
2018 -A$33.08 Million7.22%
2017 -A$30.85 Million39.68%
2016 -A$22.09 Million-37.05%
2015 -A$35.09 Million6.94%
2014 -A$32.81 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Ultragenyx Pharmaceutical
RARE
-A$0.68 Billion-28.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
A$45.98 M-104.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Recro Pharma
REPH
A$5.64 M-100.60%๐Ÿ‡บ๐Ÿ‡ธ USA